Skip links

Cerdelga® (eliglustat)

Full Name Cerdelga® (eliglustat)
Drug Cerdelga
Manufacturer Sanofi Genzyme
Route of Administration Oral
Site of Care Home
Approved Indication Long-term treatment of adult patients with Gaucher disease type 1 who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test
Disease Gaucher Type I Disease
Therapeutic Area Neurology, Genetics
Enrollment Form Link Enrollment Form
Phone Number 800-240-9572
Fax Number 877-220-7581
Product Website